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INTRODUCTION
Mammographic density which reflects the amount of fibroglandular or radio-dense tissue in the breast is a strong determinant of breast cancer risk (1) . Although the exact mechanisms underlying the association between mammographic density and breast cancer are not completely understood, both traits share several risk factors including nulliparity, late age at first birth and hormone replacement therapy (HRT) (2, 3) . Apart from an overlap in environmental risk factors, there is also evidence of a shared genetic basis. Twin studies estimate that approximately 60% of the variation in mammographic density is genetically determined (4, 5) and the polygenic mode of inheritance suggests that both traits share a large number of genetic variants (6) . To date, five single nucleotide polymorphisms (SNPs) which have been reported to be associated with mammographic density [rs10995190 in ZNF365, rs2046210 at 6q25 near ESR1 (7), rs3817198 in LSP1, rs10483813 in RAD51L1 (8) , rs13281615 at 8q24 (9) ] had previously been identified as breast cancer susceptibility SNPs, whilst only one SNP [rs1265507 at 12q24 (10) ] has been reported as being associated with mammographic density but not with breast cancer. Last year, 41 new breast cancer loci were discovered in a large collaborative effort (11) , enlarging the pool of candidate SNPs for further analysis of mammographic density.
Thus far, all studies investigating the genetic basis of mammographic density have used either qualitative or semi-automated area-based measures (4, 5, (12) (13) (14) (15) (16) . The main disadvantage of these measures is that they are reader-dependent and do not acknowledge the 3D structure of the breast.
Fully-automated measures of volumetric mammographic density may provide more accurate measures as they incorporate information on breast thickness (17, 18) . Studies comparing volumetric to area-based measures show good agreement for percent mammographic density, but the correlation for the absolute dense tissue is weak (19) (20) (21) (22) (23) . These data underscore the notion that both methods measure different aspects of the same underlying entity.
In the present study, we aimed to estimate the heritability of volumetric mammographic density and to explore the shared genetic component with breast cancer by analyzing associations with established breast cancer susceptibility loci.
METHODS

Study population
The KARolinska MAmmography project for risk prediction of breast cancer (KARMA) is a prospective cohort study initiated in January 2011 and comprises 70,866 women attending mammography screening or clinical mammography at four hospitals in Sweden (24). Upon study entry, participants responded to a web-based questionnaire, donated blood and gave permission for storage of raw full field digital mammograms.
We used two study populations to address our research questions. We used a sib-pair design for the heritability analysis including all full and half-sib pairs in KARMA. Since all women in Sweden have a unique national registration number, sister-relations can be retrieved through the Multiple Generation Register. We only considered female blood relatives for this analysis and excluded twins as their number was too small for having a meaningful contribution. We selected a separate independent sample for the breast cancer SNP analysis including unrelated women who were genotyped using the custom Illumina iSelect genotyping array (iCOGS, details described below).
The same selection criteria were applied to both samples. We included all women with raw digital mammograms who were in the age range for mammography screening in Sweden (40-74 years). We excluded women who had previous cancers other than non-melanoma skin cancer, women with breast enlargements/reductions/surgery and participants who were pregnant in the twelve months prior to study entry. We further excluded women with incomplete questionnaire data and missing information on age, BMI and menopausal status, as well as sisters with incomplete covariate data.
This resulted in a study population of 955 sib-pairs (908 full-sib and 47 half-sib pairs) for the heritability analysis and 4,025 unrelated women for the breast cancer SNP analysis. The study was approved by the ethical review committee at Karolinska Institutet and all participants provided written informed consent.
Mammographic density measures
Mammographic density was measured from the medio-lateral oblique (MLO) view using a fully automated volumetric method (Volpara TM , version 1.4.3). Technical details of the software have been described elsewhere (17) . In brief, the algorithm computes the thickness of dense tissue at each pixel using the X-ray attenuation of an entirely fatty region as an internal reference. The absolute dense volume (cm Volpara has been validated against breast magnetic resonance imaging (MRI) data and the method appears to be robust to changes in imaging conditions (17) . Moreover, we have recently shown that Volpara performs well in a high-throughput setting with both percent and absolute dense volume being associated with established density determinants and breast cancer risk (25).
Covariates
Participants filled out a detailed web-based questionnaire including information on reproductive history, use of hormone replacement therapy (HRT) and previous benign breast disease. Menopausal status was defined according to information on menstruation status, previous oophorectomy and age at study entry. Postmenopausal women were defined as those who had no periods during the last year, a history of oophorectomy, or age 55 or older. Women were considered premenopausal when they reported having periods during the past 3 months or age < 46 years if they had missing data on menstruation status. Body mass index (BMI) was calculated based on self-reported height and weight. We also collected information on body size at age 7 and 18 years by means of a nine-level somatotype, a method that has previously been validated against BMI data (26).
Genotyped and imputed SNP data
Genotyping was performed using the iCOGS array. This array comprises 211,155 SNPs which were primarily selected for replication of loci putatively associated with breast, ovarian or prostate cancer (11) . Standard SNP quality control was performed in Plink (version 1.07) (27) and SNPs with call rates < 95% and/or deviation from Hardy-Weinberg equilibrium (HWE) at P < 1x10 -5 were excluded.
For the breast cancer SNP analysis, we considered all common variants linked to breast cancer at a genome-wide significance level (P < 5 x 10 -8
) in COGS (11, 28) or previous genome-wide association studies (GWAS) as identified through the GWAS catalog (29) . We also included SNPs that were identified in recent fine-mapping studies of the TERT and 11q13 regions (30, 31) . In total 82
established breast cancer SNPs were identified. All variants were genotyped directly, except for 6 (rs11242675, rs2180341, rs9485372, rs11814448, rs2284378 and rs13393577) which were imputed using IMPUTE v2 using the 1000 Genomes Project March 2012 release as a reference.
(32). All imputed SNPs passed quality control (INFO-score > 0.80).
Statistical analysis
All mammographic measures were log-transformed prior to analyses to approximate the normal distribution. We first estimated full and half sib-pair correlations by calculating intra-class correlation coefficients (ICCs) between the residuals of each mammographic measure. Three models were used to study the influence of potential confounders. We started with a model adjusting for age and menopausal status, after which BMI was added in a second model. Age at menarche, HRT, history of benign breast disease, parity and age at first birth were then added to the final multivariable adjusted model. We also performed a sensitivity analysis with additional adjustment for height and 
where μ is the overall mean and β j is the regression coefficient of the jth individual specific covariate which takes value v ij for the ith individual. The values of g i and e i represent deviations from μ that are due to additive genetic effects and residual error respectively, and are assumed to be independently normally distributed. Heritability (h 2 ) in this case is narrow sense heritability, defined as the ratio of the variance of the additive genetic effects to the total (residual) variance in mammographic density.
Breast cancer SNP analyses were performed using tests for genotype trend effects in linear regression models with mammographic density as outcome and adjusting for age, BMI and menopausal status. For imputed SNPs, allele dosages were used in place of genotype calls. We also estimated the proportion of variance explained by all breast cancer SNPs.
Statistical tests for heritability were necessarily one-sided (H1: ICC > 0 and H1: h 2 > 0), while tests for breast cancer SNP associations were all two-sided. A Bonferroni correction was applied in the breast cancer SNP analysis to account for multiple testing with the threshold of statistical significance being defined as P = 6.10 x 10 -4 (= 0.05 divided by 82). We also calculated a more conservative threshold of .
RESULTS
Participant characteristics are summarized in Table 1 . Both populations had a mean age at study 
Sister-pair correlations and heritability of volumetric mammographic density
Overall, sib-pair correlations were stronger for percent than absolute dense volume. In full sisters, (Table 2) . Results remained unchanged after additional adjustment for height and body size at age 7 and 18 years (data not shown).
Associations with established breast cancer susceptibility loci
Results from the breast cancer SNP analysis are shown in Table 3 . Four breast cancer SNPs were found to be associated with volumetric mammographic density. The strongest association was observed for rs10995190 in the ZNF365 gene, with betas (SE) per minor allele increase being -0.05 (0.01) for percent dense volume (P = 9.0x10 -6 ) and -0.07 (0.01) for absolute dense volume (P = 8.9x10
). We also found associations of rs9485372 in the TAB2 gene with percent dense volume (P = 1.8x10
) and absolute dense volume (P = 1.8x10
), although the latter association was not statistically significant. The corresponding betas (SE) per minor allele increase were -0.09 (0.02) and -0.08 (0.03) respectively. Furthermore, two SNPs (rs9383938 in the ESR1 gene and rs2046210 upstream of ESR1)
were associated with the absolute dense volume, but not with percent dense volume: beta (SE) per minor allele increase = 0.07 (0.02) for rs9383938 (P = 2.6x10 -4 ) and 0.04 (0.01) for rs2046210 (P = 4.6x10 -4 ).
We also explored associations with the absolute nondense volume and found associations with rs6001930 in the MKL1 gene (P = 6.7x10 -6 ) and rs17356907 near the NTN4 (P = 8.4x10 -5 ).
All breast cancer SNP associations exceeded the primary and more conservative P value threshold, except for rs9383938 and rs2046210 which were only statistically significant at the primary P value threshold.
When fitted together, the established breast cancer SNPs explained 4.3% of the variance in absolute dense volume. This percentage was lower for percent dense volume and the absolute nondense volume (2.2% and 1.6% respectively).
DISCUSSION
We observed high heritability values for volumetric mammographic density, though estimates were weaker for absolute than percent dense volume. We could replicate previously observed associations of rs10995190 (ZNF365) and rs2046210 (ESR1) with mammographic density, and identified novel associations with breast cancer SNPs in 6q25: rs9485372 (TAB2) and rs9383938 (ESR1). We also found evidence of breast cancer SNP associations with the absolute nondense volume: rs6001930 (MKL1) and rs17356907 (NTN4).
Previous studies using area-based mammographic measures (4, 5, 12, 14, 16, 35) Results of our breast cancer SNP analyses are partly in line with those previously reported for areabased measures. The minor allele of rs10995190 in the ZNF365 gene was found to be associated with a lower percent dense area in the first GWAS of mammographic density (7); accordingly, we found the minor allele to be associated with lower percent and absolute dense volume. In addition, the minor allele of rs2046210 on chromosome 6q25 (upstream of the ESR1 gene) is known to be associated with higher percent and absolute dense area (7); we found it to be associated with higher absolute dense volume, but saw no association with percent dense volume (P = 0.27). Furthermore, no associations were observed with other SNPs that have previously been linked to area-based density in non-GWAS approaches (i.e. rs3817198 in the LSP1 gene, rs13281615 at chromosome 8q24 and rs10483813 in the RAD51L1 gene) (7-9). There are several possible explanations for the differences between our findings and those obtained using area-based measures. Firstly, it is important to bear in mind that whilst both mammographic dense area and dense volume attempt to capture the same information about breast composition, they are distinct measures of mammographic density. An alternative explanation may lie in differences between study populations.
Recent data show that the effect of breast cancer SNPs varies according to other environmental factors (36) and this kind of heterogeneity may explain the lack of an overall association found in this study. A third explanation is the statistical power of the different studies. Our study had 90% power to detect a 1% absolute difference in percent dense volume between homozygous carriers and noncarriers of a SNP with a minor allele frequency (MAF) of 0.16 e.g. rs10995190 (ZNF365). We had higher statistical power to detect similar effects for more common SNPs. However, our study could have been underpowered when the effect sizes of the SNPs are much smaller than the effect of the ZNF365 SNP.
Interestingly, we found evidence of two novel breast cancer SNP associations with mammographic density at 6q25: rs9383938 and rs9485372. Rs9383938 is located in the ESR1 gene and despite being in close proximity to rs2046210, both SNPs are not strongly correlated (R 2 = 0.12). Rs9485372 is located in the TGF-beta activated kinase 1/MAP3K7 binding protein 2 (TAB2) gene and has been associated with breast cancer risk in Asian women (39) . The underlying biology of this association remains to be determined, but the TGF-beta pathway plays an important role in early tumorigenesis and metastasis (40, 41) as well as mammary development (42) . The TAB2 protein also interacts directly with the N-terminal domain of ESR1 and has been implicated in pro-inflammatory induced re-activation of repressed estrogen receptor signalling pathways (43, 44 ).
For all SNPs described above, associations were in the same direction as their effect on breast cancer risk (11, 39, 45) . In addition, we found two breast cancer SNP associations for the absolute nondense volume: rs17356907 near the NTN4 gene and rs6001930 in the MKL1 gene. Both SNPs have previously been associated with an area-based measure of breast size (46), but not specifically with the nondense volume. The direction of both associations is opposite to those reported for breast cancer (11), supporting the idea that the absolute nondense volume exerts a protective effect on breast cancer risk (47, 48) .
Our study has several strengths and weaknesses. We used a fully automated density method which is expected to be less prone to measurement errors. Furthermore, SNP analyses were performed in cancer-free women, reducing the likelihood of artificial associations due to confounding by breast cancer (49, 50) . The heritability analysis was confined to full and half-sisters only. We could not retrieve cousin relations in our cohort, as this would require three generation pedigree information which is not available in the Multiple Generation Register. Also, we did not consider mother-daughter relations for our analysis, as this number would be very small given the age range for mammography screening. Further, it should be noted that genetic correlations among sisters could be affected by shared environmental effects. Heritability estimates were not materially different after adjusting for known determinants of mammographic density. Thus, inflation of our estimates due to these factors is unlikely, although we cannot rule out potential inflation by unmeasured shared environmental factors.
In conclusion, our results confirm the high heritability of mammographic density, though estimates are weaker for absolute than percent dense volume. These data support the notion that mammographic density is a risk factor under strong genetic influence that may partially explain the 
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